(Q45405407)

14 December 2017

Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy (English)

1 reference

14 December 2017

1 reference

1 reference

Kasuya H

1

1 reference

14 December 2017

Nishiyama Y

2

1 reference

14 December 2017

Nomoto S

3

1 reference

14 December 2017

Goshima F

4

1 reference

14 December 2017

Takeda S

5

1 reference

14 December 2017

Watanabe I

6

1 reference

14 December 2017

Nomura N

7

1 reference

14 December 2017

Shikano T

8

1 reference

14 December 2017

Fujii T

9

1 reference

14 December 2017

Kanazumi N

10

1 reference

14 December 2017

Nakao A

11

1 reference

14 December 2017

6 April 2007

1 reference

14 December 2017

1 reference

14 December 2017

14

1 reference

14 December 2017

6

1 reference

14 December 2017

533-542

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701049

14 December 2017

0 references

cites work

Induction of apoptosis by herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

US3 protein kinase of herpes simplex virus type 2 plays a role in protecting corneal epithelial cells from apoptosis in infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Regulation of apoptosis by viral gene products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

The fight of viruses against apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Anti-apoptotic protein kinase of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Construction of a US3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Induction of apoptosis in HEp-2 cells by infection with herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Prevention of apoptosis by a baculovirus gene during infection of insect cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Virus proteins that counteract host immune defenses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Lamin proteolysis facilitates nuclear events during apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Adenovirus E1B 19K protein is required for efficient DNA replication in U937 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Inhibition of ICE-like proteases inhibits apoptosis and increases virus production during adenovirus infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Replicating herpes simplex virus vectors for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Oncolytic herpes simplex virus vectors for cancer virotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Intratumoral injection of herpes simplex virus HF10 in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701049

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701049

1 reference

Dimensions Publication ID

14 December 2017

0 references

1 reference